Brief: OliX Enters Agreement With Pharmaron To Advance Non-Clinical Toxicology Testing For Hepatitis B Candidate OlX703A
20/10/2021 13:44
Oct 20 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ :
* OLIX PHARMACEUTICALS ENTERS AGREEMENT WITH PHARMARON TO
ADVANCE
NON-CLINICAL TOXICOLOGY TESTING FOR HEPATITIS B CANDIDATE
OLX703A
Source text for Eikon: ID:nGNX2L78tr
Further company coverage: 226950.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug
Brief: OliX Pharmaceuticals Administers First Patient In Phase 1 Clinical Study of Androgenic Alopecia Treatment